A skin wound is defined by any alteration in the integrity of the skin layers. It is
estimated that 2 million Europeans suffer from skin lesions, which is an important factor
influencing the patient's quality of life. When the skin is disrupted, the integumentary
system has the capacity to self-regenerate, a process called healing of skin lesions. It
constitutes a vital and fundamental process whose main objective is to restore the
integrity and normal function of the skin, where numerous cellular components are
involved, such as the LOX enzymes. These catalyze cross-linking reactions of collagen
and elastin in connective tissue, thus allowing cross-linking between these two
compounds in the extracellular matrix of the skin, facilitating the process of cell migration
in the wound healing process.
In order to optimize treatments to maximize the healing of cutaneous wounds,
the present dissertation had as main objective to study the impact of selected
compounds, with inhibitory activity of LOX enzymes, in the collective migration of
keratinocytes, and later development of nanoformulations for cutaneous application,
having with a view to optimizing the healing process of cutaneous wounds, contributing
to the improvement of problems related to these and possibly increasing the patient's
quality of life.
Using an in vitro assay, the effect of LOX BAPN, EPCU-5 and PN1 inhibitor
compounds on collective migration of HaCaT cells was evaluated. Contrary to what
would be expected considering the effect of this type of compounds on other cell lines,
it was observed that two of the compounds significantly increased collective cell
migration, while another compound did not have any impact on cell migration.
Subsequently, nanoformulations composed of solid lipid nanoparticles containing BAPN
were produced and developed and their stability over time was evaluated, as well as
their impact when applied to the skin. In general, the developed nanoformulations
showed stable pH, hydrodynamic diameter and polydispersion index values over the 30
days of the study. The results of the in vivo study indicate a good cutaneous compatibility
of the nanoformulations, but no differences were observed regarding the control in its
effectiveness, so future studies with a larger panel of volunteers will be necessary.
Keywords: LOX enzymes, wound healing, risk assay, collective cell migration,
nanotechnology, skin application
Date of Award | 2023 |
---|
Original language | Portuguese |
---|
Supervisor | Nuno Saraiva (Supervisor) |
---|
- PHARMACEUTICAL SCIENCES
- WOUND HEALING
- NANOTECHNOLOGY
- CUTANEOUS ADMINISTRATION
- TID:203360826
Impacto na migração de queratinócitos por modulação das enzimas LOX : aplicabilidade em formulações tópicas cutâneas
Nascimento, C. M. M. (Author). 2023
Student thesis: Master's Thesis